Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 2
2011 3
2012 6
2013 5
2014 9
2015 10
2016 7
2017 8
2018 6
2019 10
2020 10
2021 13
2022 10
2023 11
2024 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.
Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, Ceglarek U, Cineus R, Hegazy AN, van der Vorst EPC, Döring Y, Strauch CM, Nemet I, Tremaroli V, Dwibedi C, Kränkel N, Leistner DM, Heimesaat MM, Bereswill S, Rauch G, Seeland U, Soehnlein O, Müller DN, Gold R, Bäckhed F, Hazen SL, Haghikia A, Landmesser U. Haghikia A, et al. Among authors: doring y. Eur Heart J. 2022 Feb 10;43(6):518-533. doi: 10.1093/eurheartj/ehab644. Eur Heart J. 2022. PMID: 34597388 Free PMC article. Clinical Trial.
Chemokines.
van der Vorst EP, Döring Y, Weber C. van der Vorst EP, et al. Among authors: doring y. Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):e52-6. doi: 10.1161/ATVBAHA.115.306359. Arterioscler Thromb Vasc Biol. 2015. PMID: 26490276 Review. No abstract available.
Targeting immune cell recruitment in atherosclerosis.
Döring Y, van der Vorst EPC, Weber C. Döring Y, et al. Nat Rev Cardiol. 2024 Nov;21(11):824-840. doi: 10.1038/s41569-024-01023-z. Epub 2024 Apr 25. Nat Rev Cardiol. 2024. PMID: 38664575 Review.
Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice.
Cimen I, Natarelli L, Abedi Kichi Z, Henderson JM, Farina FM, Briem E, Aslani M, Megens RTA, Jansen Y, Mann-Fallenbuchel E, Gencer S, Duchêne J, Nazari-Jahantigh M, van der Vorst EPC, Enard W, Döring Y, Schober A, Santovito D, Weber C. Cimen I, et al. Among authors: doring y. Sci Transl Med. 2023 Nov;15(720):eadf3357. doi: 10.1126/scitranslmed.adf3357. Epub 2023 Nov 1. Sci Transl Med. 2023. PMID: 37910599
Immunotherapy for cardiovascular disease.
Lutgens E, Atzler D, Döring Y, Duchene J, Steffens S, Weber C. Lutgens E, et al. Among authors: doring y. Eur Heart J. 2019 Dec 21;40(48):3937-3946. doi: 10.1093/eurheartj/ehz283. Eur Heart J. 2019. PMID: 31121017 Review.
ILC2-mediated immune crosstalk in chronic (vascular) inflammation.
Kral M, van der Vorst EPC, Surnov A, Weber C, Döring Y. Kral M, et al. Among authors: doring y. Front Immunol. 2023 Dec 20;14:1326440. doi: 10.3389/fimmu.2023.1326440. eCollection 2023. Front Immunol. 2023. PMID: 38179045 Free PMC article. Review.
112 results